Shoham, Israel

Bilha Fischer

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Bilha Fischer: Innovator in Fluorescent Probes and Pharmaceutical Compounds

Introduction

Bilha Fischer is a notable inventor based in Shoham, Israel, recognized for his contributions to the field of fluorescent probes and pharmaceutical compounds. With a total of seven patents to his name, Fischer has made significant advancements in imaging techniques and therapeutic applications.

Latest Patents

Fischer's latest patents include innovative compounds and processes. One of his notable inventions is related to styryl quinolinium compounds, which are designed for selective nucleoli staining in living cells and for imaging rRNA. This invention provides a process for their synthesis and highlights their utility as fluorescent probes. Another significant patent involves uridine di- and tri-phosphate derivatives, which are useful for treating diseases modulated by P2Y receptors. These compounds are particularly aimed at lowering intraocular pressure, thereby addressing conditions such as ocular hypertension and glaucoma.

Career Highlights

Throughout his career, Bilha Fischer has worked with esteemed institutions, including Bar-Ilan University and the University of Montpellier. His research has focused on developing innovative solutions that bridge the gap between basic science and practical applications in medicine.

Collaborations

Fischer has collaborated with notable colleagues, including Victoria Nahum and Victoria Kleiman-Nahum, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Bilha Fischer's work exemplifies the intersection of scientific research and practical application, making significant strides in the fields of imaging and pharmaceuticals. His contributions continue to impact the scientific community and improve therapeutic options for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…